Trial intelligence / Profile preview

Anakinra for Hyperandrogenemia in PCOS

NCT03578497Phase 2Completed

Sponsor
University Hospital Basel
Start
Aug 2018
Primary completion
Jul 2020
Modality
Cytokines & Interferons
Countries
1
01

Overview

A Phase 2 trial of anakinra in polycystic ovary syndrome (PCOS), sponsored by University Hospital Basel. Started Aug 2018; status: completed.

02

Drugs

anakinra
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on NCT03578497.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03578497.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call